A Double-blind, Parallel Group, Randomized, Placebo Controlled Sleep Laboratory Study of Efficacy and Safety of Neu-P11 in Insomnia Patients Aged 18-80.

Trial Profile

A Double-blind, Parallel Group, Randomized, Placebo Controlled Sleep Laboratory Study of Efficacy and Safety of Neu-P11 in Insomnia Patients Aged 18-80.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jul 2013

At a glance

  • Drugs Piromelatine (Primary)
  • Indications Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Feb 2013 Results will be presented at the 27th Annual Meeting of the Associated Professional Sleep Societies (APSS), according to a Neurim Pharmaceuticals media release.
    • 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top